Actively Recruiting

Age: 18Years - 80Years
All Genders
NCT06753981

Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study

Led by Qianfoshan Hospital · Updated on 2024-12-31

48

Participants Needed

1

Research Sites

113 weeks

Total Duration

On this page

Sponsors

Q

Qianfoshan Hospital

Lead Sponsor

C

Chinese Academy of Medical Sciences, Fuwai Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study is a multicenter, prospective, observational study aimed at investigating the efficacy and safety of triple targeted drug therapy in patients with arterial pulmonary hypertension (PAH) who are not at low risk and are receiving initial treatment. The prognosis of arterial pulmonary hypertension is explored.

CONDITIONS

Official Title

Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Consent and sign the informed consent form
  • Non-low-risk PAH treatment-naive patients
Not Eligible

You will not qualify if you...

  • Positive acute vascular response test for idiopathic/hereditary/drug-related arterial pulmonary hypertension
  • Pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis (PVOD/PCH) with arterial pulmonary
  • Pregnant or lactating women
  • Suffering from mental illness or cognitive impairment
  • PAH patients with concurrent malignant tumors
  • Patients with moderate to severe hepatic impairment, renal impairment, and severe anemia
  • Currently participating in other interventional clinical studies
  • Key clinical data is incomplete, or the investigator considers that the patient has other factors that make them unsuitable for this study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China

Jinan, Shandong, China, 250014

Actively Recruiting

Loading map...

Research Team

G

Guanghai Wang, Prof.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here